Abstract

The focus of this article is to describe the etiology, clinical presentation, treatment, and molecular signaling mechanisms involved in the dermatological manifestations of nephrogenic systemic fibrosis (NSF). The pathogenesis of NSF involves the recruitment of fibrocytes to tissue where they differentiate into the pro-fibrotic myofibroblast phenotype involved in collagen deposition. This review focuses on the different pro-fibrotic molecular signaling pathways of fibroblasts that mediate skin fibrosis in NSF. This article provides an overview of the clinical presentation and treatment of NSF, with an in depth review of the signaling pathways of fibroblasts associated with the development of skin fibrosis in NSF.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.